ArticleJACC. Case reports2026
Cardiac Arrest in a Young Soccer Player With a Pathogenic SCN5A Variant.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe SCN5A gene encodes the alpha subunit of the cardiac sodium channel; variants are associated with inherited cardiac diseases including long QT syndrome, sick sinus syndrome, dilated cardiomyopathy, arrhythmogenic cardiomyopathy, and Brugada syndrome. CASE SUMMARY: A 19-year-old male soccer player with a family history of sudden cardiac death collapsed during practice and received an automated external defibrillator shock for polymorphic ventricular tachycardia. Genetic testing identified a pathogenic SCN5A c.4222G>A (p.Gly1408Arg) variant previously associated with Brugada syndrome, although no Brugada pattern was identified on electrocardiogram. A subcutaneous implantable cardioverter-defibrillator was placed. After 8 months without arrhythmias and a reassuring exercise stress test, the patient returned to competitive sports through shared decision-making. DISCUSSION: This case highlights the value of genetic testing after unexplained cardiac arrest and challenges surrounding return-to-sport decisions in inherited arrhythmia syndromes. TAKE-HOME MESSAGES: Consider genetic testing in cases of unexplained sudden cardiac arrest. Accessible automated external defibrillators are essential for safe athletic environments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.